Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance

Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Sørlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci USA, 98, 10869, 10.1073/pnas.191367098 Rakha, 2006, Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance, Eur J Cancer, 42, 3149, 10.1016/j.ejca.2006.08.015 Rakha, 2006, Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation, J Pathol, 208, 495, 10.1002/path.1916 Luck, 2008, The influence of basal phenotype on the metastatic pattern of breast cancer, Clin Oncol (R Coll Radiol), 20, 40, 10.1016/j.clon.2007.10.002 Nielsen, 2004, Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma, Clin Cancer Res, 10, 5367, 10.1158/1078-0432.CCR-04-0220 Rakha, 2007, Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression, Histopathology, 50, 434, 10.1111/j.1365-2559.2007.02638.x Dolle, 2009, Risk factors for triple-negative breast cancer in women under the age of 45 years, Cancer Epidemiol Biomarkers Prev, 18, 1157, 10.1158/1055-9965.EPI-08-1005 Trivers, 2009, The epidemiology of triple-negative breast cancer, including race, Cancer Causes Control, 20, 1071, 10.1007/s10552-009-9331-1 Uematsu, 2009, Triple-negative breast cancer: correlation between MR imaging and pathologic findings, Radiology, 250, 638, 10.1148/radiol.2503081054 Bertucci, 2008, How basal are triple-negative breast cancers?, Int J Cancer, 123, 236, 10.1002/ijc.23518 Tan, 2008, Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients, Breast Cancer Res Treat, 111, 27, 10.1007/s10549-007-9756-8 Rakha, 2009, Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes, Clin Cancer Res, 15, 2302, 10.1158/1078-0432.CCR-08-2132 Weidner, 1991, Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma, N Engl J Med, 324, 1, 10.1056/NEJM199101033240101 Toi, 1993, Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma, Int J Cancer, 55, 371, 10.1002/ijc.2910550305 Bevilacqua, 1995, Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma—results of a multiparametric study, Breast Cancer Res Treat, 36, 205, 10.1007/BF00666041 Des Guetz, 2004, Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis, Cancer Res, 64, 2941, 10.1158/0008-5472.CAN-03-1957 Choi, 2005, Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression, Mod Pathol, 18, 143, 10.1038/modpathol.3800253 Nakamura, 2005, Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer, Breast Cancer Res Treat, 91, 125, 10.1007/s10549-004-5783-x Mohammed, 2009, Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications, Breast Cancer Res Treat, 113, 261, 10.1007/s10549-008-9936-1 Pinder, 1994, Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up, Histopathology, 24, 41, 10.1111/j.1365-2559.1994.tb01269.x Gajdos, 1999, Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers, Ann Surg, 230, 692, 10.1097/00000658-199911000-00012 Lee, 2006, Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma, Eur J Cancer, 42, 357, 10.1016/j.ejca.2005.10.021 Goldhirsch, 2003, Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer, J Clin Oncol, 21, 3357, 10.1200/JCO.2003.04.576 Breiteneder-Geleff, 1999, Podoplanin—a specific marker for lymphatic endothelium expressed in angiosarcoma, Verh Dtsch Ges Pathol, 83, 270 Birner, 2001, Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer, Clin Cancer Res, 7, 93 Schoppmann, 2001, Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer, Anticancer Res, 21, 2351 Evangelou, 2005, Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach, Mod Pathol, 18, 1490, 10.1038/modpathol.3800457 Mohammed, 2007, Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences, Am J Surg Pathol, 31, 1825, 10.1097/PAS.0b013e31806841f6 Fox, 1995, Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis, J Pathol, 177, 275, 10.1002/path.1711770310 Hansen, 2004, Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients, Histopathology, 44, 428, 10.1111/j.1365-2559.2004.01848.x Zehnder, 1992, The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes, J Biol Chem, 267, 5243, 10.1016/S0021-9258(18)42758-5 Podgrabinska, 2002, Molecular characterization of lymphatic endothelial cells, Proc Natl Acad Sci USA, 99, 16069, 10.1073/pnas.242401399 Fiedler, 2006, The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors, Am J Pathol, 168, 1045, 10.2353/ajpath.2006.050554 Evans, 2007, Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up, J Med Screen, 14, 210, 10.1258/096914107782912004 Rakha, 2008, Basal-like breast cancer: a critical review, J Clin Oncol, 26, 2568, 10.1200/JCO.2007.13.1748 Rakha, 2008, Impact of basal-like breast carcinoma determination for a more specific therapy, Pathobiology, 75, 95, 10.1159/000123847 Marks, 1999, Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours, Br J Cancer, 80, 569, 10.1038/sj.bjc.6690393 Arigami, 2005, Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer, Br J Cancer, 93, 688, 10.1038/sj.bjc.6602739 Bono, 2004, High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer, Clin Cancer Res, 10, 7144, 10.1158/1078-0432.CCR-03-0826 Kato, 2005, A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity, Br J Cancer, 93, 1168, 10.1038/sj.bjc.6602844 Ingeholm, 1999, Quantification of microvessel density of breast carcinoma: an assessment of the inter- and intraobserver variation, Breast, 8, 251, 10.1054/brst.1999.0057 Obermair, 1995, Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival, Int J Cancer, 62, 126, 10.1002/ijc.2910620203 Tsutsui, 2003, Prognostic value of microvessel density in invasive ductal carcinoma of the breast, Breast Cancer, 10, 312, 10.1007/BF02967651 Costello, 1995, Prognostic significance of microvessel density in lymph node negative breast carcinoma, Hum Pathol, 26, 1181, 10.1016/0046-8177(95)90190-6 Medri, 2000, Tumor microvessel density and prognosis in node-negative breast cancer, Int J Cancer, 89, 74, 10.1002/(SICI)1097-0215(20000120)89:1<74::AID-IJC12>3.0.CO;2-L Pàez-Ribes, 2009, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis, Cancer Cell, 15, 220, 10.1016/j.ccr.2009.01.027 Ebos, 2009, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, 15, 232, 10.1016/j.ccr.2009.01.021 Rodríguez-Pinilla, 2006, Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas, Clin Cancer Res, 12, 1533, 10.1158/1078-0432.CCR-05-2281 Fulford, 2007, Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival, Breast Cancer Res, 9, R4, 10.1186/bcr1636